Stock listing

Euronext:SIGHT Gensight Biologics SA Action

Home listing (Euronext) of Gensight Biologics SA

Follow Gensight Biologics SA into a list and get an email when it puts out news.

Share price · EURONEXT:SIGHT

€0.072 EUR -0.004 (-5.0%)

Close on Oct 16, 2026

Gensight Biologics SA logo
Ticker
Euronext:SIGHT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders

Oct 16, 2026

Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa

Oct 8, 2026

GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders

Oct 8, 2026

GenSight Biologics Reports Cash Position as of September 30, 2026

Oct 7, 2026

GenSight Biologics S A Reports Cash Position as of September 30, 2026

Oct 7, 2026

GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates

Sep 30, 2026

GenSight Biologics publie ses résultats financiers du premier semestre 2026 et fait un point sur son activité

Sep 30, 2026

GenSight Biologics Provides September 2026 Business Updates

Sep 8, 2026

GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates

Jul 8, 2026

GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026

May 20, 2026

All Gensight Biologics SA news

Financings

  • Private placement of ordinary shares, pre-funded warrants and investor warrants

    Oct 16, 2026

    Closed: €1M in the latest tranche · €0.077 a share · Warrants at €0.0497 for 60 months

    Buyers: Heights Capital; Invus

    Use of proceeds: Operating activities and working capital pending the structural financing of the RECOVER Phase III trial

    Closed Oct 8, 2026 · Closed Oct 16, 2026

Read by 6ix AI from the company's releases

Decks

Gensight Biologics SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 48 in all · newest Oct 16, 2026 · oldest 2025
Decks
9 decks · latest May 19, 2026

Where Gensight Biologics SA is listed

ListingExchangeCountryCurrency
Euronext:SIGHT · Home listing · This pageEuronextFranceEUR
LSE:0RIMLSEUnited KingdomEUR
gettex:G49NgettexGermanyEUR
LS Exchange:A2ANGZLS ExchangeGermanyEUR
Lang & Schwarz:A2ANGZLang & SchwarzGermanyEUR
Aquis:SIGHTPAquisUnited KingdomEUR
OTC:GSGTFOTCUnited StatesUSD
Aquis:SIGHTPAquisUnited KingdomEUR
Dusseldorf:G49NDusseldorfGermanyEUR
Frankfurt:G49NFrankfurtGermanyEUR
Hamburg:G49NHamburgGermanyEUR
Munich:G49NMunichGermanyEUR
Stuttgart:G49NStuttgartGermanyEUR
Turquoise:SIGHTPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Gensight Biologics SA.